|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation and amortization | |||||
| Loss on disposal of property and equipment | |||||
| Change in fair value of warrant liability | |||||
| Change in fair value of PPAs liability | |||||
| Commitment fee under SEPA | |||||
| Financing costs related to PPAs | |||||
| Stock-based compensation | |||||
| Changes in operating assets and liabilities: | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable and accrued expenses | |||||
| Right-of-use assets and lease liabilities, net | |||||
| Net cash used in operating activities | |||||
| Purchases of property and equipment | |||||
| Proceeds from sale of property and equipment | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities | |||||
| Proceeds from PPAs | |||||
| Payment of financing costs related to issuance of common stock, PPAs and SEPA | |||||
| Proceeds from issuance of common stock and warrants, net of issuance costs | |||||
| Proceeds from issuance of common stock under Employee Stock Purchase Plan | |||||
| Payments for taxes related to net settlement of equity awards | |||||
| Net cash provided by financing activities | |||||
| Net decrease in cash and cash equivalents | |||||
| Cash and cash equivalents, beginning of period | |||||
| Cash and cash equivalents, end of period | |||||
| Supplemental disclosure of non-cash investing and financing activities | |||||
| Property and equipment additions included in accounts payable and accrued expenses | |||||
| Unpaid deferred financing costs | |||||
| Increase in right-of-use assets and operating lease liabilities resulting from contract modification | |||||
| PPAs related costs included in accounts payable and accrued expense | |||||
| Fair value of common stock issued in satisfaction of PPAs liability | |||||
| Equity issuance costs included in accounts payable and accrued expense | |||||
| Tax related to net settlement of equity award included in accounts payable and accrued expenses | |||||
Loading...